TMITE Trademark

Trademark Overview


On Friday, October 22, 2021, a trademark application was filed for TMITE with the United States Patent and Trademark Office. The USPTO has given the TMITE trademark a serial number of 97087381. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, March 6, 2023. This trademark is owned by Crossbow Therapeutics, Inc.. The TMITE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations, namely, ...
tmite

General Information


Serial Number97087381
Word MarkTMITE
Filing DateFriday, October 22, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, March 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Pseudo MarkT MIGHT
Goods and ServicesPharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations, namely, antivirals
Pseudo MarkTMIGHT
Pseudo MarkT MITE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, March 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCrossbow Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameCrossbow Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, March 6, 2023ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Monday, March 6, 2023ABANDONMENT - AFTER PUBLICATION
Saturday, March 4, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, October 13, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 8, 2022EXAMINER'S AMENDMENT ENTERED
Monday, August 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 8, 2022EXAMINERS AMENDMENT E-MAILED
Monday, August 8, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 1, 2022ASSIGNED TO EXAMINER
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 26, 2021NEW APPLICATION ENTERED